DADATA·ANALYSIS
FREE
company · cik 1671584

Aptevo Therapeutics Inc.

APVONasdaqSIC 2834public
financials · annual · usd2026
Revenue$3.1M
Net income-$26.0M
Total assets$27.2M
Total liabilities$9.8M
Equity$17.4M
LT debt$1.5M
Operating cash-$25.6M
money-flow · companies

No customer / supplier links anchored.

commodity exposure

No commodity exposure anchored.

places · hq + contracts1